Anti-angiogenic effects of VEGF stimulation on endothelium deficient in phosphoinositide recycling | Nature Communications
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis: Cell
Frontiers | Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
IJMS | Free Full-Text | Markers of Angiogenesis, Lymphangiogenesis, and Epithelial–Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion
Tumor angiogenesis: causes, consequences, challenges and opportunities | SpringerLink
IJMS | Free Full-Text | Targeting Tumor Endothelial Cells with Nanoparticles
Cells | Free Full-Text | Trends and Challenges in Tumor Anti-Angiogenic Therapies
Imaging Key Biomarkers of Tumor Angiogenesis
The potential use of matrix-derived anti-angiogenic molecules in human... | Download Scientific Diagram
Frontiers | Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer
Anti-angiogenic biomarkers | Phase I Biomarker Laboratory
Angiogenesis in Cancer: Novus Biologicals
Current data on predictive markers for anti-angiogenic therapy in thoracic tumours | European Respiratory Society
Angiogenesis and Its Therapeutic Opportunities
Pro‐ and antiangiogenic therapies: current status and clinical implications - Rust - 2019 - The FASEB Journal - Wiley Online Library
Tumor angiogenesis: causes, consequences, challenges and opportunities | SpringerLink
Anti-angiogenic biomarkers | Phase I Biomarker Laboratory
Frontiers | Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies
Tumor angiogenesis: molecular pathways and therapeutic targets | Nature Medicine
3D Microfluidic Platform and Tumor Vascular Mapping for Evaluating Anti- Angiogenic RNAi-Based Nanomedicine | ACS Nano
Gold nanoparticles and angiogenesis: molecular mechanisms and biomedic | IJN
